Related Experiment Video
Updated: May 4, 2026

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
Relationships between body fat accumulation, aerobic capacity and insulin resistance in Japanese participants
Eiichi Yoshimura1, Hideaki Kumahara2, Takuro Tobina3
1Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Aim:
This study evaluated the relationships between body fat accumulation, aerobic capacity and insulin resistance (HOMA-IR) in 61 Japanese participants.
Method:
The participants were middle-aged to elderly (age: 33-73; BMI: 21.6-38.5). Body fat mass (FM) was evaluated by hydrostatic weighing. Computed tomography was used to evaluate visceral and subcutaneous fat areas (VFA and SFA), liver to spleen ratio (L/S), and low-density muscle area (LDMA). To assess aerobic capacity, VO2 at the lactate threshold (VO2@LT) and VO2 peak were measured using a bicycle ergometer.
Results:
FM, VFA, SFA, LDMA and L/S significantly correlated with HOMA-IR, but VO2@LT and VO2 peak did not. Analysis of covariance after adjustment for VFA or other body fat distribution and aerobic capacity showed that HOMA-IR had a significant linear trend across the tertile groups of L/S. However, for FM, VFA, SFA, LDMA and VO2@LT or VO2 peak, no significant trend was observed between the tertiles and insulin resistance.
Conclusions:
Ectopic fat deposition in the liver may influence insulin resistance independently of other body fat accumulation and aerobic capacity in Japanese participants.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
Related Concept Videos
Obesity
Type II Diabetes II: Pathophysiology
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Type II Diabetes I: Introduction